A Cluster Randomised Trial Introducing Rapid Diagnostic Tests into Registered Drug Shops in Uganda: Impact on Appropriate Treatment of Malaria

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Jul 23

PMID 26200467

Citations 58

Authors

Anthony K Mbonye

Pascal Magnussen

Sham Lal

Kristian S Hansen

Bonnie Cundill

Clare Chandler

Sian E Clarke

Affiliations

Soon will be listed here.

Abstract

Background: Inappropriate treatment of malaria is widely reported particularly in areas where there is poor access to health facilities and self-treatment of fevers with anti-malarial drugs bought in shops is the most common form of care-seeking. The main objective of the study was to examine the impact of introducing rapid diagnostic tests for malaria (mRDTs) in registered drug shops in Uganda, with the aim to increase appropriate treatment of malaria with artemisinin-based combination therapy (ACT) in patients seeking treatment for fever in drug shops.

Methods: A cluster-randomized trial of introducing mRDTs in registered drug shops was implemented in 20 geographical clusters of drug shops in Mukono district, central Uganda. Ten clusters were randomly allocated to the intervention (diagnostic confirmation of malaria by mRDT followed by ACT) and ten clusters to the control arm (presumptive treatment of fevers with ACT). Treatment decisions by providers were validated by microscopy on a reference blood slide collected at the time of consultation. The primary outcome was the proportion of febrile patients receiving appropriate treatment with ACT defined as: malaria patients with microscopically-confirmed presence of parasites in a peripheral blood smear receiving ACT or rectal artesunate, and patients with no malaria parasites not given ACT.

Findings: A total of 15,517 eligible patients (8672 intervention and 6845 control) received treatment for fever between January-December 2011. The proportion of febrile patients who received appropriate ACT treatment was 72·9% versus 33·7% in the control arm; a difference of 36·1% (95% CI: 21·3 - 50·9), p<0·001. The majority of patients with fever in the intervention arm accepted to purchase an mRDT (97·8%), of whom 58·5% tested mRDT-positive. Drug shop vendors adhered to the mRDT results, reducing over-treatment of malaria by 72·6% (95% CI: 46·7- 98·4), p<0·001) compared to drug shop vendors using presumptive diagnosis (control arm).

Conclusion: Diagnostic testing with mRDTs compared to presumptive treatment of fevers implemented in registered drug shops substantially improved appropriate treatment of malaria with ACT.

Trial Registration: ClinicalTrials.gov NCT01194557.

Citing Articles

How does the medicines retail sector ensure continued access to medicines during public health emergencies? Lessons from the COVID-19 pandemic in Uganda.

Hutchinson E, Mundua S, Myers J, Clarke S, Hansen K, Mayora C J Pharm Policy Pract. 2025; 18(1):2418977.

PMID: 39881951 PMC: 11776061. DOI: 10.1080/20523211.2024.2418977.

Evaluating the impact of malaria rapid diagnostic tests on patient-important outcomes in sub-Saharan Africa: a systematic review of study methods to guide effective implementation.

Otieno J, Were L, Sagam C, Kariuki S, Ochodo E BMJ Open. 2024; 14(9):e077361.

PMID: 39260846 PMC: 11409401. DOI: 10.1136/bmjopen-2023-077361.

Improving malaria case management with artemisinin-based combination therapies and malaria rapid diagnostic tests in private medicine retail outlets in sub-Saharan Africa: A systematic review.

Goodman C, Tougher S, Shang T, Visser T PLoS One. 2024; 19(7):e0286718.

PMID: 39074113 PMC: 11285950. DOI: 10.1371/journal.pone.0286718.

A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: Results of the TESTsmART trial in Lagos, Nigeria.

Visser T, Laktabai J, Kimachas E, Kipkoech J, Menya D, Arthur D PLOS Glob Public Health. 2024; 4(7):e0002938.

PMID: 38954701 PMC: 11218985. DOI: 10.1371/journal.pgph.0002938.

A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: results of the TESTsmART Trial in Lagos, Nigeria.

Visser T, Laktabai J, Kimachas E, Kipkoech J, Menya D, Arthur D medRxiv. 2024; .

PMID: 38352390 PMC: 10862997. DOI: 10.1101/2024.01.30.24302026.

References

Barnish G, Bates I, Iboro J . Newer drug combinations for malaria. BMJ. 2004; 328(7455):1511-2. PMC: 437132. DOI: 10.1136/bmj.328.7455.1511. View

Kindermans J, Vandenbergh D, Vreeke E, Olliaro P, DAltilia J . Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs). Malar J. 2007; 6:91. PMC: 1948000. DOI: 10.1186/1475-2875-6-91. View

Kyabayinze D, Tibenderana J, Odong G, Rwakimari J, Counihan H . Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda. Malar J. 2008; 7:221. PMC: 2584069. DOI: 10.1186/1475-2875-7-221. View

Ansah E, Narh-Bana S, Epokor M, Akanpigbiam S, Quartey A, Gyapong J . Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana. BMJ. 2010; 340:c930. PMC: 2833239. DOI: 10.1136/bmj.c930. View

van der Geest S . Self-care and the informal sale of drugs in south Cameroon. Soc Sci Med. 1987; 25(3):293-305. DOI: 10.1016/0277-9536(87)90232-2. View

Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O . Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004; 329(7476):1212. PMC: 529364. DOI: 10.1136/bmj.38251.658229.55. View

Awor P, Wamani H, Bwire G, Jagoe G, Peterson S . Private sector drug shops in integrated community case management of malaria, pneumonia, and diarrhea in children in Uganda. Am J Trop Med Hyg. 2012; 87(5 Suppl):92-96. PMC: 3748528. DOI: 10.4269/ajtmh.2012.11-0791. View

Abraha I, Montedori A . Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ. 2010; 340:c2697. PMC: 2885592. DOI: 10.1136/bmj.c2697. View

Goodman C, Brieger W, Unwin A, Mills A, Meek S, Greer G . Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?. Am J Trop Med Hyg. 2008; 77(6 Suppl):203-18. PMC: 2657822. View

10.

Hansen K, Pedrazzoli D, Mbonye A, Clarke S, Cundill B, Magnussen P . Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda. Health Policy Plan. 2012; 28(2):185-96. PMC: 3584993. DOI: 10.1093/heapol/czs048. View

11.

Ivers N, Halperin I, Barnsley J, Grimshaw J, Shah B, Tu K . Allocation techniques for balance at baseline in cluster randomized trials: a methodological review. Trials. 2012; 13:120. PMC: 3503622. DOI: 10.1186/1745-6215-13-120. View

12.

Nankabirwa J, Zurovac D, Njogu J, Rwakimari J, Counihan H, Snow R . Malaria misdiagnosis in Uganda--implications for policy change. Malar J. 2009; 8:66. PMC: 2671516. DOI: 10.1186/1475-2875-8-66. View

13.

Mbonye A, Lal S, Cundill B, Hansen K, Clarke S, Magnussen P . Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda. Malar J. 2013; 12:131. PMC: 3637132. DOI: 10.1186/1475-2875-12-131. View

14.

Steinhardt L, Chinkhumba J, Wolkon A, Luka M, Luhanga M, Sande J . Patient-, health worker-, and health facility-level determinants of correct malaria case management at publicly funded health facilities in Malawi: results from a nationally representative health facility survey. Malar J. 2014; 13:64. PMC: 3938135. DOI: 10.1186/1475-2875-13-64. View

15.

Abuya T, Mutemi W, Karisa B, Ochola S, Fegan G, Marsh V . Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar J. 2007; 6:57. PMC: 1872028. DOI: 10.1186/1475-2875-6-57. View

16.

Chong C, Cho P, Na B, Ahn S, Kim J, Lee J . Evaluation of the accuracy of the EasyTest™ malaria Pf/Pan Ag, a rapid diagnostic test, in Uganda. Korean J Parasitol. 2014; 52(5):501-5. PMC: 4210732. DOI: 10.3347/kjp.2014.52.5.501. View

17.

Hutchinson E, Hutchison C, Lal S, Hansen K, Kayendeke M, Nabirye C . Introducing rapid tests for malaria into the retail sector: what are the unintended consequences?. BMJ Glob Health. 2017; 2(1):e000067. PMC: 5321379. DOI: 10.1136/bmjgh-2016-000067. View

18.

Ndyomugyenyi R, Neema S, Magnussen P . The use of formal and informal services for antenatal care and malaria treatment in rural Uganda. Health Policy Plan. 1998; 13(1):94-102. DOI: 10.1093/heapol/13.1.94. View

19.

OConnell K, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E . Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J. 2011; 10:326. PMC: 3227612. DOI: 10.1186/1475-2875-10-326. View

20.

Mbonye A, Ndyomugyenyi R, Turinde A, Magnussen P, Clarke S, Chandler C . The feasibility of introducing rapid diagnostic tests for malaria in drug shops in Uganda. Malar J. 2010; 9:367. PMC: 3020157. DOI: 10.1186/1475-2875-9-367. View